* New clinical studies (227) include clinical trials, post authorization studies and medical device studies.
New
187
New clinical trials
32
EOM (Post authorization study)
8
MD (Medical device study)
Active
590
Clinical trials
219
EOM (Post authorization study)
40
MD (Medical device study)
47
Clinical Trials on Rare Diseases
139
Clinial Trials on Pediatrics
1,067
Clinical Trials patient inclusions in 2021
Active Clinical Studies 5-year evolution
Patient inclusions 5-year evolution
Active Clinical Studies by Research Area
82
Oncology
138
Vascular Biology and Metabolism (VAM)
188
Neurosciences
100
Infectious Diseases
91
Digestive and Liver Diseases
148
Immunomediated Diseases and Innovative Therapies
40
Obstetrics, Pediatrics And Genetics
15
Research in Surgery
47
Others
Billing evolution of clinical studies
| 2017 | 2018 | 2019 | 2020 | 2021 | |
| Phase I-II | 2.46M€ | 1.55M€ | 2.36M€ | 2.42M€ | 3.26M€ |
| Phase III | 3.03M€ | 3.52M€ | 3.19M€ | 3.36M€ | 4.34M€ |
| Phase IV | 0.27M€ | 0.14M€ | 0.11M€ | 0.14M€ | 0.29M€ |
| EOM/MD | 0.34M€ | 0.42M€ | 0.78M€ | 0.35M€ | 0.35M€ |
| TOTAL | 6.06M€ | 5.63M€ | 0.64M€ | 6.28M€ | 8.24M€ |
Methodology and Definitions
Change in criteria with respect to previous reports: The data are at VHIR level, not at Campus level (not including data from VHIO/Adult Oncology and Hematology Services).
The data includes commercial and academic studies that are registered in the database.
Research Area “Others”: studies of researchers who are not part of any research area of VHIR but belong to a Service of Vall d’Hebron Hospital.
New: studies with signed contract+AEMPS+CEIm.
Active: active+new+closed studies in the year.
